Antimicrobial susceptibility of Bacillus anthracis strains from Hungary | Zendy

Zsuzsa Kreizinger | Zendy; Kinga M. Sulyok | Zendy; László Makrai | Zendy; Zsuzsanna Rónai | Zendy; László Fodor | Zendy; Szilárd Jánosi | Zendy; Miklós Gyuranecz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial susceptibility of Bacillus anthracis strains from Hungary

Author(s) -

Zsuzsa Kreizinger,

Kinga M. Sulyok,

László Makrai,

Zsuzsanna Rónai,

László Fodor,

Szilárd Jánosi,

Miklós Gyuranecz

Publication year - 2016

Publication title -

acta veterinaria hungarica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 33

eISSN - 1588-2705

pISSN - 0236-6290

DOI - 10.1556/004.2016.015

Subject(s) - microbiology and biotechnology , cefotaxime , ciprofloxacin , erythromycin , bacillus anthracis , penicillin , antibiotics , clindamycin , rifampicin , vancomycin , biology , gentamicin , bacteria , staphylococcus aureus , genetics

The susceptibility of 29 Bacillus anthracis strains, collected in Hungary between 1933 and 2014, was tested to 10 antibiotics with commercially available minimum inhibitory concentration (MIC) test strips. All strains were susceptible to amoxicillin, ciprofloxacin, clindamycin, doxycycline, gentamicin, penicillin, rifampicin, and vancomycin. Intermediate susceptibility to erythromycin and cefotaxime was detected in 17.2% (5/29) and 58.6% (17/29) of the strains, respectively. Correlations were not observed between the isolation date, location, host species, genotype, and antibiotic susceptibility profile of strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research